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Abstract
Background: Diabetic mellitus and periodontal disease have bilateral associations. However, there is a dilemma on
the effect of periodontal therapy on glycemic control and/or fasting plasma glucose level in type 2 diabetic
patients with periodontitis. Therefore, this review aimed to assess the effectiveness of periodontal therapy versus no
periodontal therapy on glycated hemoglobin (HbA1c) and fasting plasma glucose level in type 2 diabetic patients.
Methods: Article searching was done using four databases (MEDLINE, Cochrane library (CENTRAL), EMBASE and
CINAHL) and a manual search (until December 2015). We included randomized controlled trials testing the
effectiveness of periodontal therapy on glycated hemoglobin and fasting plasma glucose level in patients with type
2 Diabetes mellitus with periodontal disease. Studies published in English between 2005 and 2015 were included.
Risk of bias was assessed regarding randomization, allocation sequence concealment, blinding, incomplete
outcome data, selective outcome reporting, and other biases.
Results: After the article selection process, seven Randomized controlled trials involving 940 participants with a
primary outcome of change in glycated hemoglobin and/or fasting plasma glucose and having a minimum of
3 months follow-up were included.
There was a reduction of glycated hemoglobin 0.48(95 % CI: 0.18–0.78) after 3 months follow-up and 0.53
(95 % CI: 0.24–0.81) at the end of the intervention period.
There was also a significant reduction of fasting plasma glucose level, 8.95 mg/dl (95 % CI: 4.30–13.61) in the
intervention group after the end of the intervention. The pooled analysis showed that patients with adjunctive
antibiotic therapy and mouth wash had effect size of 0.51(0.03, 1.00, p = 0.04) and it was 0.53 (95 % CI: 0.19, 0.87;
p = 0.002) in patients without adjunctive therapy. The publication bias of the studies was 0.066 according to
Egger’s test.
Conclusion: In this systematic review and meta-analysis, there is a significant reduction of Glycated hemoglobin
and Fasting plasma glucose level on type 2 diabetic and periodontal patients with non-surgical periodontal
therapy.
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Background
Periodontal disease is a chronic bacterial infection of the
gingival, Periodontium, and the bone that support the
tooth, which is caused by gram-negative anaerobic mi-
croorganisms that adhere to teeth as a bacterial plaque
[1]. The frequency and severity of periodontitis are more
in patients with systemic diseases (HIV/AIDS, diabetes
mellitus (DM), and cardiovascular disease) and on preg-
nancy than healthy individuals [2].
Periodontal disease and DM are the two major chronic
diseases which have a devastating effect on the health
and wellbeing of millions of individuals globally. The
prevalence of periodontitis is 10 % to 15 % of adult healthy
patient [3]. However, type 2 DM patients have 2.8 times
affected by periodontitis [4] and 4.2 times more likely to
have alveolar bone loss than non-diabetic patients [4] . An
emerging body of evidence has been reported that peri-
odontal disease causes poor glycemic control and induced
diabetes-related complications [5, 6].
Observational studies consistently showed that DM is
one of the risk factors for the severity and progression of
gingivitis and periodontal disease [7–12]. On the other
hand, periodontal disease may be a possible risk factor
for poor glycemic control and promote the existence of
diabetic complications [9, 13]. In addition, it has been
showed that periodontal disease has a devastating effect
on glycemic control among type 2 diabetic patients and
a significant reduction of Glycated hemoglobin(HA1c),
0.40 %, was observed after 3–4 months of periodontal
therapy done on patients with both type 1 and 2 DM
and periodontitis [14].
Impairment of glycemic control in diabetic patients
can cause a decline in polymorphonucleate leukocytes
activity. It can also damage the micro vascular endothe-
lium which as a result can cause periodontal disease
[15]. Diabetic patients with severe periodontitis are six
times to have poor glycemic control than patients with
healthy periodontium [16]. However, improved glycemic
control has been postulated to reduce the severity of
periodontal disease [16].
Non-surgical periodontal therapy (mechanical removal
of pathogenic bacteria from the periodontium using
Scaling and root planning (SRP) technique) has a benefi-
ciary effect on the healing process of the periodontal tis-
sue in healthy individuals. However, the healing process
of the periodontium on diabetic patients depends on the
level of glycemic control. The presence of a positive
association between periodontal therapy and glycemic
control has a significant clinical impact because every
1 % reduction in HbA1c significantly reduces the risk of
diabetic complications [17].
Some literatures supported the hypothesis of peri-
odontal therapy has a positive effect on glycemic control,
which in turn reduces the incidence of diabetic related
complications [18–21]. However, some studies showed
there is no association between periodontal therapy and
glycemic control in diabetic patients [22–25]. Due to this
inconsistency in literature, there is conflict on clinical as-
pects to make a clinical recommendation with confidence.
Therefore, this systematic review and meta-analysis is
intended to answer the following question: in type 2 dia-
betic patients with periodontal disease, does periodontal
therapy (compared to no therapy) have a reduction on
the effect of glycemic and fasting plasma glucose level?
Methods
Protocols and registration
The systematic review was done using the preferred
reporting items for systematic reviews and meta-analysis
(PRISMA) checklist. There was no registration done
either for the protocol or the systemic review.
Eligibility criteria
The types of included studies were Randomized con-
trolled trials (RCTs) which studied the effectiveness of
periodontal therapy on glycemic control and/or fasting
plasma glucose level in type 2 DM with periodontitis.
Full text articles published in English (as translation
funding was not available), done on type 2 diabetic pa-
tients with periodontitis, periodontal treatment with/
without adjunctive treatment, and outcome of change in
glycated hemoglobin and/or fasting plasma glucose.
Information sources
Studies were identified by searching electronic databases
(MEDLINE, EMBASE, CINAHL and Cochrane Library
(CENTRAL)) and scanning reference lists of articles and
using manual search. Articles published in English lan-
guage were selected. The search was started in May 2015
and ended in December 2015 for all databases.
Data search
Four databases (were used during article selection
process from their inception to December 2015. In
addition to this, a manual search of articles was done
from following journals; Dental research journal, Journal
of dental research, Journal of Clinical Periodontology,
Journal of periodontal research, Journal of the American
dental association, Clinical Diabetes, Diabetes Care, and
Diabetes research and Clinical Practice.
We used the following search keywords to search all
clinical trials registers and databases: “periodontal therapy
and type 2 diabetes; periodontal disease and type 2
diabetes mellitus; periodontal disease and glycemic con-
trol; periodontal disease and Diabetes mellitus.
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Article selection
The two authors searched articles electronically in data-
bases and manually. To identify relevant articles; titles and
abstracts of retrieved papers were exported to Endnote
where duplicates were identified and removed by one
reviewer (AT).
All retrieved articles were evaluated by two independ-
ent reviewers (AT, AY). A conflict between these two
reviewers was resolved by consensus. After excluding
the non-eligible articles, they were screened according to
their titles and abstracts. Full-text articles were assessed
and the articles which didn’t meet the inclusion criteria
were excluded (Fig. 1).
Type of intervention
The intervention groups receive non-surgical periodontal
therapy with/without adjunctive antibiotics or mouth
wash while the control groups didn’t receive periodontal
therapy until the end of the intervention period (Table 1).
Risk of bias assessment with in the studies
The two reviewers (AT, AY) assessed the risk of bias of
the individual articles independently. The risk of bias of
each included trial was assessed both at the study and
outcome level with the following parameters; random
sequence generation, allocation concealment, blinding of
the examiner and/or patient, incomplete data outcome
and loss to follow-up [26]. These parameters were
assessed using the standardized form prepared by the
Cochrane group [18] (Fig. 2 ).
Data extraction
The two reviewers (AT, AY) extracted data from the
selected randomized controlled trial (RCT) studies using
pre-designed forms independently. Any conflict between
these two reviewers was resolved by consensus. Data
was extracted from each RCT on (1) demographic char-
acteristics (including mean age, sample size, country of
the study done); (2) definition of periodontitis; (3) defin-
ition of diabetes (type 2DM, duration, Initial and Final
results of HA1c, initial and final results of fasting plasma
glucose (FPG) level); (4) type of intervention and (5) the
type of outcomes (glycated hemoglobin/fasting plasma
glucose) (Table 1).
Change in HbA1c between baseline and final result



















302 articles after duplicates removed
53 full-text articles assessed for eligibility











ty 46 articles were excluded
4. 28 articles were systematic/meta-analysis studies
5. 10 articles: the intervention didn’t meet the inclusion 
criteria





 7 studies included in qualitative and 
quantitative synthesis
Fig. 1 Flow diagram showing the article selection process
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Mean age Inclusion criteria of













Greece I = 30
C = 30
I = 59.62 ± 7.95
C = 59.42 ± 9.8
Type 2DM A1C levels





I = 7.76 ± 4.33
C = 7.84 ± 6.80
having at least 16 teeth
present with at least eight
sites (PPD) >6 mm and
four sites with CAL >5 mm,
distributed in at least two
different quadrants.
I = SRP + OHI
C = delayed treatment
6 months HbA1c HbA1c Changes within
the 1st 3 month
I: 0.73 ± 0.66
C: 0.18 ± 0.59
HbAIc changes after
6th months
I: 0.72 ± 0.93
C: 0.13 ± 0.46
Kumar et al.,
2015 [30]
India I = 15
C = 15




I = 8.13 ± 0.67
C = 8.09 ± 0.76
FPG (mg/dl) base line
I = 153.63 ± 13.02




2. Patients who have
undergone periodontal
treatment 6 months prior
to the study
I = SRP and systemic
Doxycycline
C = no treatment
3 months HbA1c HbA1c Changes after
3rd month
I = 7.31 ± 0.50
C = 8.16 ± 0.74
Change in FPG after
three months
I = 145.47 ± 11.17




India I = 35
C = 35
I = 47.14 ± 5.28




I = 8.49 ± 1.50
C = 8.04 ± 0.70
Initial FPG Level
I = 131.31 ± 21.48
C = 127.34 ± 19.89
Diabetes duration
I = 1–15 years
C = 1–15 years
1. pocket depth [PD] 4–6 mm
involving >30 % sites)
2. generalized moderate
periodontitis






I = 8.47 ± 0.89
C = 8.27 ± 0.63
FPG changes after
3rd months
I = 122.64 ± 17.81
C = 136.57 ± 15.07
Engebretson et al.,
2013 [34]
USA I = 257C
= 257
I = 56.7 ± 10.5
C = 57.9 ± 9.6
Type 2Dm
HbA1c level
7.0 % −9.0 %
Initial HbA1c:
I = 7.84 (0.65)
C = 7.78 (0.60)
Baseline FPG
I = 150 (125–174)
C = 147 (122–172)
Diabetes duration
I = 12.3 (8.2)
C = 11.3 (8.4)
1. a minimum of 16 natural
teeth
2. CAL/PD >5 mm in 2 or
more quadrants of the
mouth
3. No periodontal treatment
in the prior 6 months.







Mean Change of HbA1c
(95 % CI) at 3rd month
I = 0.14(0.02–0.27)
C = 0.11(−0.02 to 0.24)
Mean Change of HbA1c
(95 % CI) at the end of
6th month
I = 0.15(−0.01 to 0.30)















Table 1 Characteristics of studies included in the meta-analysis and change in HbA1c and FPG level (Continued)
Gay et al.,
2014 [35]
USA I = 66
C = 60






I = 9.0 ± 2.3
C = 8.4 ± 2.0
2. nonsmokers
1. no systemic antibiotic
therapy within 6 months
of recruitment,
2. the presence of localized
or generalized severe
chronic periodontitis
I = SRP + OHI
C = OHI
4 months HbA1c HbA1c Changes after
4th month
I = 8.4 ± 1.9
C = 8.1 ± 1.8
Kaur et al., 2015
[31]
India I = 50
C = 50




I = 8.17 ± 2.49
C = 7.87 ± 2.56
2. Duration of DM
I = 8.57 ± 6.39
C = 7.05 ± 4.43
FPG (mmol/L)
I = 137.12 ± 59.71
C = 120.74 ± 41.47
1. presence of ≥12 teeth
2. ≥2 interproximal sites, not
on the same tooth, with an
attachment loss ≥4 mm,
or PD ≥5 mm.
3. ≥2 interproximal sites, not
on the same tooth, with an
attachment loss ≥6 mm,
and one or probing
depth ≥5 mm
I = OHI + SRP
C = no treatment
3,6 months HbA1c HbA1c Changes in the
end of 3rd month.
I = 7.49 ± 1.83
C = 7.96 ± 2.65
HbA1c Changes in the
end of 6th month.
I = 7.29 ± 1.61
C = 8.06 ± 2.72
Change in FPG after
three months
I = 135.88 ± 59.54
C = 121.71 ± 42.39
Change in FPG after
six months.
I = 132.10 ± 56.91,
C = 122.75 ± 42.67
Telgi et al., 2013
[33]
India I = 20
C = 20
NA 1. Type 2 DM
Initial HbA1c:
I = 7.68 ± 0.63






I = 210.50 ± 4.98
C = 210.5 ± 41.98
1. the presence of aminimum
of 28 teeth
2. pocket depth of 4–5 mm)








3 month HbA1c HbA1c after 3 month
I = 7.10 ± 0.64
C = 7.75 ± 0.48
FPG after three month
I = 181.70 ± 41.28















the study. The difference in HbA1c percentage in each
treatment was recorded. When there is no documented
difference, it was calculated by extracting the mean
change of glycated hemoglobin in the experimental and
control group.
Change in FPG between baseline and final result after
periodontal therapy was the second outcome of the
study. The mean difference of FPG was registered in
each treatment follow-up (Table 1).
Statistical analysis
All data extracted from the studies were submitted and
analyzed using RevMan 5.3 software [27]. The Meta ana-
lysis was performed, comparing the experimental group
who got periodontal therapy and the control group
which didn’t get periodontal treatment. From the se-
lected studies, mean difference was calculated using ran-
dom effect model. The heterogeneity of the studies was
assessed by I-square. The publication bias of the articles
was assessed using GRADE, funnel plot and Egger’s test.
Results
Study selection
A total of 367 articles were retrieved using four elec-
tronic databases (MEDLINE, EMBASE, CINAHL and
Cochrane library) and manually searching. After removal
of the duplicates 302 articles were remained. Out of
those 249 articles were excluded during title and abstract
screening, because these papers did not meet the inclu-
sion criteria. Two independent reviewers (AT, AY) have
scanned these journals using the predesigned form based
on the title and the abstract of the paper. Fifty three full-
text Articles were selected and assessed in more detail
for eligibility. Seven articles met the inclusion criteria
and were included in the systematic review and Meta-
analysis (Fig. 1).
Fig. 2 Risk of bias assessment table within studies
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Study characteristics
Methods
All seven studies selected for the Meta- analysis were
randomized controlled trials published in English. Four
of them were done in India [28–31], two of them were
in USA [32, 33], and the remaining one was conducted
in Greece [34]. All of the studies included patients hav-
ing periodontitis and type 2 DM as study subjects
(Table 1).
Participants
The included studies involved 473 participants (range
15–257 patients per study) in the intervention group
and 467 participants (range 15–257 patients per study)
in the control group. The mean age ranges from
47.14(±5.2) to 59.62(±7.95) years in the intervention
group and from 48.86 (±3.8) to 59.42(±9.8) in the con-
trol group. The baseline level of HA1c ranged from 7.0
to 9.9 % in the intervention group while it was ranged
from 7.0 to 10.2 % in the control group (Table 1).
Intervention
All patients in the intervention group received scaling
and root planning with systemic doxycycline [28], mouth
wash [31, 32] and without adjunctive antimicrobials or
mouth wash [29, 30, 33, 34] while the control group
received any form of periodontal intervention (Table 1).
Outcomes
In all studies the primary outcomes assessed were change
in HA1c level and change in fasting plasma glucose level
after the intervention level.
Risk of bias within studies
To ascertain the validity of eligible randomized con-
trolled trials the two reviewers assessed the risk of bias
of the selected studies using the following parameters.
Random sequence generation, allocation concealment,
blinding of the personnel and participants, intention to
analysis, incomplete outcome data addressed and selecting
reporting. All of the articles reported status of incomplete
outcome data, intention to treat analysis and selecting
reporting. Random sequence generation and allocation
concealment were not clearly stated in two studies
[32, 33] (Fig. 2).
Risk of bias across the studies
The risk of bias across the studies was assessed using
GRADE profile and it was moderate as presented in
Fig. 3.
Fig. 3 GRADE evidence summary for the assessment of risk of bias across the included studies
Fig. 4 Funnel plot showing the distribution of the studies
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We assessed the possibility of publication bias by
evaluating a funnel plot of the mean difference for asym-
metry. The funnel plot revealed an asymmetrical distribu-
tion of the included studies (Fig. 4), and the publication
bias was 0.066 in Egger’s test.
Exploration of heterogeneity
In this random effects model, the heterogeneity (I2)
among the selected seven studies is 99 % (p = 0.0003),
suggesting the 99 % of the variability in treatment effect
estimates is due to real study difference (heterogeneity)
and only 1 % due to chance (Fig. 6).
Results of individual studies
The effect of periodontal therapy on glycemic control of
type 2 diabetic patients was analyzed from the available
randomized clinical trial studies. All of the studies
showed a reduction in HA1c after three to four months
follow-up [28–34] and there was a moderate difference
of HA1c level between the baseline and end of the
intervention. Four studies showed a change in FPG level
from baseline to 3 months [28–31] (Table 1).
The effect of periodontal therapy on glycated hemoglobin
(HbA1c)
The mean difference in HA1c ranged from 0.02 (±0.61)
to 0.88 (±0.66) in the intervention group and −0.23
(±0.07) to 0.3(±0.2) in the control group. A significant
reduction of HbA1c was observed in the pooled analysis
between the intervention and control group with a
random effect of: 0.48 (95 % CI: 0.18, 0.78, p = 0.002) at
the end of 3 months follow-up and a mean difference of
0.53 (95 % CI: 0.24, 0.81, p = 0.0003) with overall effect
of Z = 3.63 after the end of the intervention period
(Figs. 5 and 6).
Subgroup analysis of the studies was done depending
on their intervention type (adjunctive antibiotic/mouth
wash use or not). There was a statistically significant re-
duction of HA1c in the intervention group in those with
adjunctive therapy: 0.51(95 % CI: 0.03, 1.00; p = 0.04)
with 95 % heterogeneity and in non-adjunctive therapy:
Fig. 5 Meta-analysis showing the pooled effect of periodontal therapy on glycemic control at the end of 3 months follow-up
Fig. 6 Meta-analyis showing the pooled effect of periodontal therapy on glycemic control at the end of the treatment
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0.53(95 % CI: 0.19, 0.87; p = 0.002) with 91 % heterogen-
eity (Figs. 7 and 8).
Periodontal treatment and fasting plasma glucose level
There was a mean difference of FPG level ranged from
5.02 (±2.8) mg/dl to-28.8 (±36.3) mg/dl in the interven-
tion group while it was ranged from-9.23(±4.82) mg/dl
to 0.4(±1.04) mg/dl in the control group. The effect of
periodontal therapy on fasting plasma glucose was done
in four studies. The computed mean difference was
8.95 mg/dl (95 % CI: 4.30, 13.61), favoring the interven-
tion group (Fig. 9).
Discussion
Uncontrolled diabetes mellitus has adverse effects on the
health of the periodontium, which in turn, have a dele-
terious effect on the glycemic level of type 2 diabetic
patient. The pathophysiology of this effect is associated
with altered host response, inflammation, and insulin
resistance [12]. In this meta-analysis, we analyzed data
from seven randomized controlled trials, targeted at
evaluating whether periodontal therapy had an influence
on glycemic control in patients with both type 2 DM
and periodontitis.
In this meta-analysis, the included articles comprised
of a total population of 940 patients (473 patients in the
intervention and 467 patients in the control group). It
has large sample size than the previous studies [24, 35,
36]. The mean difference in HbA1c ranged from 0.02
(±0.61) to 0.88 (±0.66) in the intervention group and from
−0.23 (±0.07) to 0.3(±0.2) in the control group. There was
a mean difference of FPG level ranged from 5.02 (±2.8)
mg/dl to-28.8 (±36.3) mg/dl in the intervention group
while it was ranged from −9.23(±4.82) mg/dl to 0.4(±1.04)
mg/dl in the control group.
Even though there were literature investigating the ef-
fect of periodontal therapy on glycemic control [18–23],
there has not been consistence and complementary evi-
dence on the effects of periodontal therapy on glycemic
control and/or fasting plasma glucose levels. Some of
the literature showed positive effect of periodontal ther-
apy on glycemic control [18–21]. On the other hand,
some researchers reported periodontal therapy has no
effect on glycemic control besides its effect on periodon-
tal health [22–25]. The present study is in favor of the
hypothesis suggesting periodontal therapy has a benefi-
cial effect on HbA1c and FPG reduction.
In the present meta-analysis, there was a moderate re-
duction of HA1c level in the intervention group, with a
random effect size of 0.53 % HbA1c (95 % CI: 0.24, 0.81)
among the seven studies which is statistically significant.
This result is consistent with the results of the previous
Meta-analyses done by Engebretson et al. (0.36 % (95 %
CI −0.54, −0.19 %) [19], Teeuw et al. (−0.40 % (95 % CI
−0.77, −0.04 %, P = 0.03) [37], Liew et al., (0.41 % (95 %
CI: _0.73 %, _0.09 %,) [20], Darre’ et al. 0.46 (95 % CI
0.11, 0.82) [21] and Sun et al. (1.21 %(95 % CI: 0.75,
1.68) [35]. This comparable result indicates periodontal
therapy has a moderate impact on the reduction of
HbA1c after the treatment. However, a study done by
Janket et al. (0.57 %, p = 0.82) [24] and Wang etal
(−0.238, 95 % CI: −0.616 , 0.14; p = 0.217) [36] showed
that there was a non-significant decrease of HbA1c
between the intervention and the control group. This
Fig. 7 Meta-analysis showing the effect of adjunctive use of antibiotics and mouth wash along with periodontal therapy on glycemic control
Fig. 8 Meta-analysis showing the effect of periodontal therapy without adjunctive antibiotics/mouthwash on glycemic control on type 2
diabetic patients
Teshome and Yitayeh BMC Oral Health  (2017) 17:31 Page 9 of 11
discrepancy might be due the small number of included
studies and small sample size which may be insufficient
to demonstrate significant differences [36].
In this meta-analysis, subgroup analysis of the studies
was done depending on their intervention type (adjunct-
ive antibiotic/mouth wash use or not). There was a sta-
tistically significant reduction of HA1c in both the
intervention groups with adjunctive therapy; 0.51(95 %
CI: 0.03, 1.00; p = 0.04) and non-adjunctive therapy:
0.53(95 % CI: 0.19, 0.87; p = 0.002). This result showed
that the reduction of glycated hemoglobin depends on the
presence of periodontal therapy and the presence of
adjunctive antibiotic or mouth wash has no effect on gly-
cemic control.
The result of this meta-analysis showed that periodon-
tal therapy could lead to a significant reduction in FPG
levels with effect size of 8.95 mg/dl (95 % CI: 4.30, 13.61;
p = 0.0002) at the end of the intervention. This result is
almost similar with the result of a study done by Wang
et al. [36], which showed a significant decrease in FPG
after 3–4 months of follow-up (−9.01 mg/dl (95 % CI
−2.24 to −15.78; p = 0.009) and (−13.62 mg/dl, 95 % CI:
0.45 to −27.69) after 6 months (P = 0.06). However, a study
done by Sun et al. [35] showed there was no significant
difference in plasma fasting glucose level between the ex-
perimental and control groups after 3 months follow-up.
The limitation of this systematic review and meta-
analysis was searching of literatures was restricted to full
text articles published in English language due to finan-
cial problems. Majority of the included studies have a
small sample size which could lead this systematic re-
view and Meta-analysis to small-study effect. Variation
in baseline HbA1c level among the studies and the pres-
ence of different periodontal definition and treatment
period was observed in the selected studies which could
bring an inconsistent result in the systematic review and
Meta-analysis.
The other limitation of this systematic review with
Meta- analysis is that some of the included articles
didn’t report the standard deviation of change in FPG
and HbA1c, and the data were obtained by calculation.
Conclusion
The Meta analysis result supports the effectiveness of
periodontal therapy in glycemic control in type 2 diabetic
patients and periodontitis. However, large sample size
Randomized controlled trials must be done to confirm
this association.
Clinical application
This result indicates that the use of periodontal treatment
along with oral hypoglycemic drugs (agents) has a signifi-
cant impact on glycemic control and/or fasting plasma
glucose level. Based on this implication Type 2 DM
patients with periodontitis are advised to have a regular
periodontal treatment and follow up so that they can re-
duce the incidence of diabetic related complications.
It is advisable if dental and endocrinology departments
have a bilateral link to prevent the diabetic related com-
plications of those patients with periodontal disease and
Type 2 DM.
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